Back
Intellia Therapeutics Stock Price Chart
$1,300 into $45,000 in just 4 MONTHS?!
See here to see the full details.
Sell
35
NTLA
Intellia Therapeutics
Last Price:
26.52
Seasonality Move:
-8.55%
7 Day Trial
ALL ACCESS PASS
$
7
Wall Street's Worst Nightmare: Small Town Trader's AI Edge
See the AI advantage for everyday Americans.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing slight selling pressure.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.21 | Buy |
| 20-day SMA: | 24.52 | Buy |
| 50-day SMA: | 24.39 | Buy |
| 200-day SMA: | 26.51 | Sell |
| 8-day EMA: | 25.84 | Buy |
| 20-day EMA: | 25.12 | Buy |
| 50-day EMA: | 24.62 | Buy |
| 200-day EMA: | 27.74 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.65 | Buy |
| Relative Strength Index (14 RSI): | 58.12 | Buy |
| Chaikin Money Flow: | -199475 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.8 - 26.04) | Buy |
| Bollinger Bands (100): | (22.43 - 27.25) | Buy |
Intellia Therapeutics Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 26.42 while NTLA 8-day simple moving average is 26.21, which is a Buy signal.
- The stock price of NTLA is 26.42 while Intellia Therapeutics 20-day SMA is 24.52, which makes it a Buy.
- Intellia Therapeutics 50-day simple moving average is 24.39 while NTLA share price is 26.42, making it a Buy technically.
- NTLA stock price is 26.42 and Intellia Therapeutics 200-day simple moving average is 26.51, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
35
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a Sell
The current Intellia Therapeutics [NTLA] share price is $26.42. The Score for NTLA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
2.55B
Price in USD:
26.42
Share Volume:
1.96M
Intellia Therapeutics 52-Week Range
52-Week High:
43.06
52-Week Low:
19.37
Sell
35
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?
The Intellia Therapeutics stock price is 26.42 USD today. -
Will NTLA stock go up or go down?
Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Intellia Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 26.42 while NTLA 8-day exponential moving average is 25.84, which is a Buy signal.
- The stock price of NTLA is 26.42 while Intellia Therapeutics 20-day EMA is 25.12, which makes it a Buy.
- Intellia Therapeutics 50-day exponential moving average is 24.62 while NTLA share price is 26.42, making it a Buy technically.
- NTLA stock price is 26.42 and Intellia Therapeutics 200-day simple moving average is 27.74, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.41 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
- NTLA Moving Average Covergence Divergence (MACD) indicator is 0.65, suggesting Intellia Therapeutics is a Buy
- Intellia Therapeutics Relative Strength Index (RSI) is 58.12, which suggest Intellia Therapeutics is overbought
- The Bollinger Bands (25) for Intellia Therapeutics is (22.8 - 26.04), which suggest Intellia Therapeutics is a Buy
- The Bollinger Bands (100) for Intellia Therapeutics is (22.43 - 27.25), which suggest Intellia Therapeutics is a Buy
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.